Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Management of systemic vasculitis
Autore:
Langford, CA;
Indirizzi:
NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA NIAID Bethesda MD USA 20892 mmunoregulat Lab, NIH, Bethesda, MD 20892 USA
Titolo Testata:
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
fascicolo: 2, volume: 15, anno: 2001,
pagine: 281 - 297
SICI:
1521-6942(200106)15:2<281:MOSV>2.0.ZU;2-O
Fonte:
ISI
Lingua:
ENG
Soggetto:
GIANT-CELL ARTERITIS; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; TAKAYASU-ARTERITIS; MICROSCOPIC POLYANGIITIS; PULSE CYCLOPHOSPHAMIDE; MYCOPHENOLATE-MOFETIL; CLINICAL-FEATURES; RANDOMIZED TRIAL;
Keywords:
vasculitis; arteritis; Wegener; treatment; toxicity; glucocorticoid; cytotoxic; cyclophosphamide; methotrexate;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
51
Recensione:
Indirizzi per estratti:
Indirizzo: Langford, CA NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA NIAID Bethesda MD USA 20892 Lab, NIH, Bethesda, MD 20892 USA
Citazione:
C.A. Langford, "Management of systemic vasculitis", BEST PR R C, 15(2), 2001, pp. 281-297

Abstract

The systemic vasculitides are a wide-ranging group of diseases that are characterized by the presence of blood vessel inflammation. Despite this common feature, each type of vasculitis has a unique variety of clinical manifestations that influences its degree of disease severity and ultimately its management. Immunosuppressive therapy forms the foundation of treatment foralmost all forms of systemic vasculitis. Because of this, treatment can beassociated with its own risk of morbidity, or even mortality, related to specific medication side-effects or infections which occur as a result of impaired host defences. This chapter seeks to review the approach to management in selected forms of systemic vasculitis. Questions examined include thefollowing. When should one treat systemic vasculitis! How does the nature of the disease and its severity affect treatment decisions! What are the data regarding the effectiveness of individual therapeutic regimens?.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 30/11/20 alle ore 12:38:55